Form 4 for BDC BELDEN INC.
Accepted 2024-11-05 00:00:00 ET · period of report 2024-11-01 · accession 0000950170-24-121270 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-05 | 2024-11-01 | BDC | Tate Leah | SVP - HR | D - Sale to Iss | $115.89 | -4,590 | 23.6K | -16% | -$531.9K |
| DM | 2024-11-05 | 2024-11-01 | BDC | Tate Leah | SVP - HR | M - OptEx | $60.00 | +6,990 | 24.4K | +40% | +$419.4K |
| DM | 2024-11-05 | 2024-11-01 | BDC | Tate Leah | SVP - HR | M - OptEx | $0.00 | -6,990 | 3,333 | -68% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-01 | D | D | 920 | $115.89 | 24,237 | D | — | — | (F3) This represents the difference between the number of SARs exercised (1,528) and the number of shares issued as a result of the exercise (608). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($115.887) and the exercise price ($51.14). Additional shares were then withheld to satisfy the Company's tax withholding obligations. |
| 2 | Common | Common Stock | 2024-11-01 | M | A | 1,528 | $51.14 | 25,157 | D | — | — | |
| 3 | Common | Common Stock | 2024-11-01 | D | D | 1,359 | $115.89 | 25,643 | D | — | — | (F6) This represents the difference between the number of SARs exercised (1,667) and the number of shares issued as a result of the exercise (308). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($115.887) and the exercise price ($85.77). Additional shares were then withheld to satisfy the Company's tax withholding obligations. |
| 4 | Common | Common Stock | 2024-11-01 | M | A | 1,667 | $85.77 | 27,002 | D | — | — | |
| 5 | Common | Common Stock | 2024-11-01 | D | D | 547 | $115.89 | 25,335 | D | — | — | (F5) This represents the difference between the number of SARs exercised (884) and the number of shares issued as a result of the exercise (337). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($115.887) and the exercise price ($53.79). Additional shares were then withheld to satisfy the Company's tax withholding obligations. |
| 6 | Common | Common Stock | 2024-11-01 | M | A | 884 | $53.79 | 25,882 | D | — | — | |
| 7 | Common | Common Stock | 2024-11-01 | D | D | 987 | $115.89 | 24,998 | D | — | — | (F4) This represents the difference between the number of SARs exercised (1,748) and the number of shares issued as a result of the exercise (761). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($115.887) and the exercise price ($45.11). Additional shares were then withheld to satisfy the Company's tax withholding obligations. |
| 8 | Common | Common Stock | 2024-11-01 | M | A | 1,748 | $45.11 | 25,985 | D | — | — | |
| 9 | Common | Common Stock | 2024-11-01 | M | A | 1,163 | $61.79 | 24,406 | D | — | — | |
| 10 | Common | Common Stock | 2024-11-01 | D | D | 777 | $115.89 | 23,629 | D | — | — | (F1) This represents the difference between the number of SARs exercised (1,163) and the number of shares issued as a result of the exercise (386). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($115.887) and the exercise price ($61.79). Additional shares were then withheld to satisfy the Company's tax withholding obligations. |
| 11 | Derivative | Stock Appreciation Rights | 2024-11-01 | M | D | 1,163 | $0.00 | 0 | D | $61.79 · 2020-02-28 to 2029-02-28 | 1,163 Common Stock | (F7) The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date. |
| 12 | Derivative | Stock Appreciation Rights | 2024-11-01 | M | D | 884 | $0.00 | 441 | D | $53.79 · 2023-02-22 to 2032-02-22 | 884 Common Stock | (F7) The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date. |
| 13 | Derivative | Stock Appreciation Rights | 2024-11-01 | M | D | 1,528 | $0.00 | 0 | D | $51.14 · 2021-02-11 to 2030-02-11 | 1,528 Common Stock | (F7) The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date. |
| 14 | Derivative | Stock Appreciation Rights | 2024-11-01 | M | D | 1,748 | $0.00 | 0 | D | $45.11 · 2022-02-16 to 2031-02-16 | 1,748 Common Stock | (F7) The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date. |
| 15 | Derivative | Stock Appreciation Rights | 2024-11-01 | M | D | 1,667 | $0.00 | 3,333 | D | $85.77 · 2024-03-07 to 2033-03-07 | 1,667 Common Stock | (F7) The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date. |